Clinical Trial

Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo

Recruiting
View on ClinicalTrials.gov →
Summary
Our randomized controlled double blind clinical trail aims to compare maternal and neonatal infectious morbidity between women with meconium-stained amniotic fluid treated with zinacef vs. placebo.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-22.
Trial Details
NCT Number NCT06849037
Lead Sponsor Western Galilee Hospital-Nahariya
Conditions Meconium-stained Amniotic Fluid, Chorioamnionitis
Enrollment 182 participants
Start Date 2025-02-18
Primary Completion 2028-02-13 (estimated)
Study Completion 2029-02-13 (estimated)
Updated on ClinicalTrials.gov 2025-07-20